SAMSUNG ELECTRONICS CO., LTD. et al. v. OMNI MEDSCI, INC.

IPR2025-01251

Apple has filed an IPR petition seeking to invalidate Omni MedSci’s ’484 wearable health‑monitoring patent. The petition argues the claims are obvious over a combination of five prior‑art references and requests that the Board institute the trial.

Jurisdiction
US PTAB
Case Number
IPR2025-01251
Filing Date
8 May 2025
Status
ok

Related Cases

patentIPR2024-01362

Apple Inc.vsVaria Holdings LLC

Apple has filed an IPR petition seeking to invalidate 19 claims of Varia’s RFID‑enabled mobile device patent, asserting obviousness over multiple prior‑art references. The petition argues that the claims lack novelty and meet PTAB discretionary standards for institution.

patentIPR2025-00883

Hisense USA Corporation et al.vsVideoLabs, Inc.

Hisense has filed an IPR petition challenging eight claims of VideoLabs' ’304 patent, asserting anticipation and obviousness over the Russ and Robert patents.

patentIPR2025-01408

Google LLCvsTelcom Ventures LLC

Google petitions the PTAB to invalidate Telcom Ventures' 9,832,708 patent covering NFC‑based smartphone payments, asserting obviousness over Barnett, Byrne, and White references.

patentIPR2025-00848

Taiwan Semiconductor Manufacturing Company Limited et al.vsMarlin Semiconductor Ltd. et al.

TSMC and Apple have filed a petition to invalidate Marlin Semiconductor's FinFET patent, arguing that the claims are obvious in view of multiple prior‑art references. The petition seeks institution of an IPR covering claims 1‑12.

patentIPR2024-01142

AT&T Enterprises, LLC et al.vsASUS Technology Licensing Inc.

Multiple major carriers, including AT&T and T-Mobile, have filed a Petition challenging ASUS Technology Licensing Inc.'s '868 patent on grounds of obviousness. The petitioners argue that the core concepts related to beam correspondence and higher layer signaling in 5G NR were anticipated or rendered obvious by prior art references Jung and Xiong. This challenge targets several claims relating to advanced wireless communication methods.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call